Which immunization should a nurse administer to a middle adult client who is immunocompromised prior to discharge?

The pneumococcal polysaccharide vaccine (PPSV) is particularly important for immunocompromised individuals. This vaccine helps protect against pneumococcal disease, which can lead to severe infections such as pneumonia, meningitis, and bacteremia. Immunocompromised patients have a weakened immune system that makes them more susceptible to infections, including those caused by pneumococcus.

Administering the PPSV vaccine can significantly reduce the risk of these serious diseases, helping to improve the overall health outcomes for the client as they transition from hospital to home care. It is especially critical for middle-aged adults with compromised immunity due to conditions such as cancer, HIV/AIDS, or those on immunosuppressive drugs.

While the other vaccines listed may also be important for various populations, they do not specifically address the enhanced risk of pneumococcal infections in immunocompromised individuals. For instance, while the influenza vaccine is crucial for protecting against the flu, it does not cover pneumococcal disease. The shingles vaccine is aimed at preventing herpes zoster, which is particularly relevant in older adults but may not be prioritized in this case. The Tdap vaccine protects against tetanus, diphtheria, and pertussis, but is